Baricitinib vs Methotrexate

Baricitinib vs Methotrexate: Overview

This comparison examines the pharmacological differences between Baricitinib and Methotrexate.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Methotrexate — C20H22N8O5.

Molecular Weight: Baricitinib — 371.4170 g/mol; Methotrexate — 454.4400 g/mol.

Type: Baricitinib — Small molecule; Methotrexate — Small molecule.